INTERSTITIAL LUNG DISEASES
Clinical trials for INTERSTITIAL LUNG DISEASES explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASES trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks nintedanib's long-term effects on scleroderma lung disease
Disease control OngoingThis study follows 2,000 people with systemic sclerosis-associated interstitial lung disease (SSc-ILD) who are taking nintedanib. Researchers want to see how the drug affects lung function, quality of life, and survival over time. Participants are already part of the EUSTAR regis…
Matched conditions: INTERSTITIAL LUNG DISEASES
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 17, 2026 09:09 UTC
-
Lung scarring may alter immunotherapy success in cancer patients
Knowledge-focused OngoingThis study examines how well immunotherapy works in people who have both lung cancer and pulmonary fibrosis (lung scarring). Researchers will review medical records of 200 patients and analyze tumor tissue at a cellular level to understand why some respond differently. The goal i…
Matched conditions: INTERSTITIAL LUNG DISEASES
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC